GCA
BIIB icon

Gideon Capital Advisors’s Biogen BIIB Stock Holding History

Gideon Capital Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,016
Closed -$306K – 379
2018
Q4 		$306K Buy
+1,016
New +$324K 0.12% 259
2018
Q3 		– Sell
-1,152
Closed -$334K – 349
2018
Q2 		$334K Buy
+1,152
New +$324K 0.17% 232
2018
Q1 		– Sell
-1,022
Closed -$326K – 348
2017
Q4 		$326K Sell
1,022
-619
-38% -$199K 0.29% 139
2017
Q3 		$514K Buy
1,641
+323
+25% +$95.6K 0.51% 40
2017
Q2 		$358K Sell
1,318
-1,138
-46% -$301K 0.39% 98
2017
Q1 		$672K Buy
2,456
+890
+57% +$252K 0.4% 49
2016
Q4 		$445K Buy
+1,566
New +$464K 0.28% 114

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Gideon Capital Advisors's BIIB Position: Q1 2019 in Review

Gideon Capital Advisors sold out of Biogen (BIIB) in Q1 2019, closing a stake of 1,016 shares — an estimated $306K sold.

Gideon Capital Advisors first reported a position in BIIB in Q4 2016 and held it in 7 quarters. The position peaked at $672K in Q1 2017. 1,085 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

  • Gideon Capital Advisors reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
  • Gideon Capital Advisors sold 1,016 Biogen shares in Q1 2019, an estimated $306K.
  • Gideon Capital Advisors first reported a position in Biogen in Q4 2016 and held it in 7 quarters.
  • Gideon Capital Advisors's Biogen position peaked at $672K in Q1 2017.
  • 1,085 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Gideon Capital Advisors's 13F filing for Q1 2019, filed 14 May 2019.